Trials / Unknown
UnknownNCT05354076
Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Fudan University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To study the correlation between the content of natural IgM in patients' blood samples and liposomal doxorubicin for clinical use, and to explore the possibility of using natural IgM content to guide clinical accurate medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | doxorubicin hydrochloride liposome injection | According to the clinical diagnosis and treatment norms, it is suitable for patients with advanced malignant tumors diagnosed by histopathology with doxorubicin hydrochloride liposome injection chemotherapy.(For breast cancer patients: liposomal doxorubicin 35mg/m2 q3w) |
Timeline
- Start date
- 2000-03-01
- Primary completion
- 2022-06-01
- Completion
- 2022-11-01
- First posted
- 2022-04-29
- Last updated
- 2022-04-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05354076. Inclusion in this directory is not an endorsement.